scispace - formally typeset
L

Li Bo Zou

Researcher at Shenyang Pharmaceutical University

Publications -  14
Citations -  629

Li Bo Zou is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Silibinin & Liquiritigenin. The author has an hindex of 11, co-authored 14 publications receiving 578 citations.

Papers
More filters
Journal ArticleDOI

Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment

TL;DR: Silibinin dose-dependently ameliorated the impairment of recognition memory caused by METH treatment in mice and found a correlation between the recognition values and dopamine and serotonin contents of the prefrontal cortex and hippocampus.
Journal ArticleDOI

Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memory

TL;DR: Results indicate that continuous infusion of thiorphan into the cerebral ventricle causes cognitive dysfunction by raising the level of Abeta in the cerebral cortex, and suggest that a reduction of neprilysin activity contribute to the deposition of AbETA and development of AD.
Journal ArticleDOI

Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice

TL;DR: It is suggested that xanthoceraside attenuates memory impairments through amelioration of oxidative stress and inflammatory responses induced by Aβ25–35 and is a potential candidate for an AD treatment.